‘Behind the Blue’: An oral history on 5 years of COVID-19 in Kentucky

LEXINGTON, Ky. (March 6, 2025) — It’s hard to believe it’s been five years since the COVID-19 pandemic officially arrived in the Commonwealth, but on Friday, March 6, 2020, Gov. Andy Beshear confirmed the state’s first COVID-19-positive patient and declared a state of emergency in Kentucky. And that first case was tested and diagnosed right here at the University of Kentucky Albert B. Chandler Hospital.

That day began a grueling, years-long grind for medical professionals across the state, the country, and the world. Hospital systems struggled to keep up with surges of severely ill patients coming through their doors. Shortages of personal protective equipment, ventilators, ECMO machines, inpatient beds and even health care providers themselves led to a type of global health crisis not seen in more than a century. 

In this episode of “Behind the Blue,” eight longtime employees from the medical side of UK’s campus, ranging from administrators to frontline health care providers to researchers reflect on those scary, early days of the pandemic, how it impacted their professional and personal lives and some of the lessons learned from living through such a significant moment in history. A full transcript of this episode is available here. 

The panelists for this oral history of the COVID-19 pandemic at UK and in the Commonwealth:

• Jenn Alonso has been at UK HealthCare for 13 years and has worked in the medicine intensive care unit (MICU) as a registered nurse since 2014. As a MICU nurse, she works alongside a team of physicians, nurses, therapists and other providers to take care of some of the most critically ill patients who come to UK HealthCare. Alonso was working in the MICU the day UK’s first COVID-19 patient was admitted and was directly involved in frontline care for the sickest COVID-19 patients day in and day out.
   
• Kim Blanton, D.N.P., is the chief nursing officer for UK Albert B. Chandler Hospital. Blanton began her nursing career at UK in 1998 in the neuro-trauma ICU and worked her way up through several nursing positions, including rapid response nursing, working as a division charge nurse and managing the cardiovascular stepdown unit. After briefly leaving UK to help create and run an ICU at a local rural hospital, she returned in 2011 as a hospital operations administrator before becoming the UK HealthCare enterprise director for Infection Prevention and Control (IPAC) and Quality and Safety.
  
  Blanton was serving in her IPAC role when the COVID-19 pandemic began and was instrumental in UK’s COVID-19 response: she helped bring home UK students from abroad, called COVID-19 patients to help them navigate their care and quarantine, developed plans and processes for patient surges and PPE needs and much more.
   
• Kevin Hatton, M.D., Ph.D., is the chief medical officer for UK Albert B. Chandler Hospital. An anesthesiologist by training, he earned both his medical degree and doctorate of philosophy degree from UK. Including his time in residency, Hatton has worked at UK HealthCare for 21 years, serving in a variety of leadership roles in anesthesiology in critical care medicine, primarily for neurology and cardiovascular ICUs. When the pandemic began, he was serving as senior medical director for critical care services and interim director for ECMO services. Initially, Hatton’s role focused on training and preparing the anesthesia critical care team to help provide care for non-COVID ICU patients, as much of the medicine ICU staff’s time was spent caring for COVID-positive inpatients.
  
  ECMO, the highest form of life support, is a machine that takes over function of a patient’s damaged heart and/or lungs by removing a patient’s blood, oxygenating it and returning it into the body. Though ECMO is used on a daily basis at UK HealthCare, its use skyrocketed during the pandemic as patients whose lungs were severely damaged by the virus needed this highest form of life support. As interim director for ECMO services, Hatton and his team had to rapidly develop protocols and processes to use the limited number of ECMO machines to help the most patients possible.
   
• Ashley Montgomery-Yates, M.D., has been a physician in the UK Division of Pulmonary, Critical Care and Sleep Medicine since 2013. As a critical care physician, she works primarily in the MICU setting taking care of the sickest patients — people on ventilators, with multi-organ failure, post-operative complications, and more. In 2013, she launched UK HealthCare’s ICU Recovery Clinic, which helps patients who have been in the ICU navigate the follow-up care and resources they need to recover. At the time, UK HealthCare’s ICU Recovery Clinic was just one of three in the nation.
  
  Montgomery-Yates is currently the senior vice chair for the Department of Internal Medicine. When the pandemic began, she had recently become the interim chief medical officer for inpatient and emergency services. In this role and as an ICU physician, Montgomery-Yates and her colleagues were heavily involved in the day-to-day care of inpatients with COVID-19. She was part of the team that launched UK’s successful mass COVID-19 Vaccine Clinic out at Kroger Field, and her ICU teams also helped guide the creation of UK HealthCare’s brand-new MICUs, which opened January 2024.
   
• Meg Pyper is a division charge nurse with the UK Albert B. Chandler Hospital Emergency Department and has been with UK HealthCare Emergency Medicine since 2010. As a charge nurse, her role is like air traffic control for the ED — taking calls from EMS and local hospitals about incoming patients and transfers, determining what services that patient will need upon arrival, and notifying interdisciplinary team members to be prepared when those patients arrive. As a nurse, she was drawn to emergency medicine after seeing her favorite nurse mentors be “the calm in the chaos.” Pyper began in this role just weeks before the pandemic arrived in Kentucky, and she and her team were the first line of care COVID patients received when they arrived at UK Chandler Hospital.
   
• Lindsay Ragsdale, M.D., is the chief medical officer for Kentucky Children’s Hospital and chief of the Division of Pediatric Palliative Care. Since arriving at UK in 2013, she has worked to build a robust program that helps seriously ill young patients and their families by caring for them holistically — looking at their physical, mental, emotional and spiritual well-being, and helping them navigate the experience of being severely ill. 
  
  Ragsdale became the KCH CMO in 2021, right when the COVID-19 delta variant was beginning to affect children much more than previous variants had. She helped set up both the pediatric monoclonal antibody clinic that provided infusions to help protect high-risk pediatric patients, as well as the successful pediatric vaccine clinic, which provided COVID-19 vaccines for children in a playful, engaging environment.
   
• Rob Sprang is the director of UK TeleCare, a role he’s held at UK since 1996. UK first began using telehealth services in 1995. Since then, telehealth has grown by leaps and bounds, but its use skyrocketed during the pandemic. Earlier days of telehealth were usually done facility-to-facility — however, the vastly improved technology and public acceptance of telehealth, along with new, more relaxed regulatory laws around its use has allowed telehealth to explode in popularity.
  
  When the pandemic hit Kentucky, Sprang and his team — along with countless ambulatory providers and staff – worked 24/7 for more than a week to get UK HealthCare clinics set up to offer telehealth so that patients could still see their providers without needing to go into the hospital or clinic. Telehealth was a critical element in helping to protect both patients and providers from potential exposure to COVID-19.
   
• Vince Venditto, Ph.D., is an associate professor of pharmaceutical sciences in the UK College of Pharmacy with a background in chemistry, drug delivery and vaccine development. In the early days of the pandemic, his work in blood analysis — looking for biomarkers for cardiovascular disease in up to 1,500 samples at a time — was adapted to do mass testing for COVID antibodies as a means of diagnosis. After PCR tests became the gold standard for diagnosing the disease, his work shifted again — this time to working with local pharmacies for surveillance of COVID out in Kentucky communities.
  
  Post-COVID, this project has evolved to include other infectious diseases and inflammatory conditions, and it focuses on increasing access to health care through Kentucky’s network of pharmacies. It also has a new name: Pharmacy-based Recruitment Opportunities To Enhance Community Testing and Surveillance (PROTECTS). Venditto co-directs this project along with Brooke Hudspeth, Pharm.D., an associate professor of pharmacy practice and science.
  
  Venditto is also part of The Consortium for Understanding and Reducing Infectious Diseases in Kentucky (CURE-KY), which fosters multidisciplinary collaborations to address the burden of infectious diseases in the Commonwealth and beyond. This consortium was built on the heels of UK’s COVID-19 Unified Research Experts (CURE) Alliance, which was quickly assembled in 2020 to support a full range of COVID-related research.

About “Behind the Blue”

“Behind the Blue” is available via a variety of podcast providers, including iTunes and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK’s latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university.

“Behind the Blue” is a joint production of the University of Kentucky and UK HealthCare. Transcripts for this or other episodes of “Behind the Blue” can be downloaded from the show’s blog page. 

To discover how the University of Kentucky is advancing our Commonwealth, click here.